Business · 21/12/2000Updated: 10/17/2026 · 1 min read
FDA Announces Submission of Information Collection for OMB Review
Summary
The Food and Drug Administration (FDA) has submitted a request for the Office of Management and Budget (OMB) to review and clear a proposed collection of information related to changes in approved New Drug Applications (NDAs) and Abbreviated New Drug Applications (ANDAs) under the Paperwork Reduction Act of 1995.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →